ROBERT ERIC BOOKSTEIN, MD
Medical Practice in Los Angeles, CA
License number
California G56957
Category
Medical Practice
Type
Molecular Genetic Pathology
Address
Address
2
8700 Beverly Blvd., Los Angeles, CA 90048
8956 La Jolla Scenic Dr N, La Jolla, CA 92037
8956 La Jolla Scenic Dr N, La Jolla, CA 92037
Phone
(310) 423-3277
(858) 736-6581
(858) 736-6581
Personal information
See more information about ROBERT ERIC BOOKSTEIN at radaris.comName
Address
Phone
7965 Caminito Del Cid, La Jolla, CA 92037
8956 La Jolla Scenic Dr N, La Jolla, CA 92037
La Jolla, CA
3024 Cranbrook Ct, La Jolla, CA 92037
7965 Caminito Del Cid, La Jolla, CA 92037
Professional information
See more information about ROBERT ERIC BOOKSTEIN at trustoria.com
Dr. Robert E Bookstein, La Jolla CA - MD (Doctor of Medicine)
Dr. Robert E Bookstein, La Jolla CA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
8956 La Jolla Scenic Dr N, La Jolla 92037
Certifications:
Anatomic Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1984
Yale University
Graduated: 1984
Prostate/Colon Tumor Suppressor Gene Located On Human Chromosome 8
Prostate/Colon Tumor Suppressor Gene Located On Human Chromosome 8
US Patent:
6043088, Mar 28, 2000
Filed:
May 22, 1995
Appl. No.:
8/445515
Inventors:
Robert Bookstein - La Jolla CA
William B. Isaacs - Glyndon MD
William B. Isaacs - Glyndon MD
Assignee:
Canji, Inc. - San Diego CA
Johns Hopkins University - Baltimore MD
Johns Hopkins University - Baltimore MD
International Classification:
C12N 508, C12N 100, C12N 1563, C07H 2104
US Classification:
435366
Abstract:
This invention provides a novel nucleic acid molecule encoding a prostate/colon tumor suppressor gene product. The means and methods for detecting mutations and/or loss of prostate/colon tumor suppressor gene are provided. Also included within the scope of this invention are methods of suppressing the neoplastic phenotype of cancer cells having a defect in the prostate/colon tumor suppressor gene product. The invention also includes the means and methods for treating the cancer by administering the prostate/colon tumor suppressor gene.